• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Biomarkers| Big Data| News, Analysis, Insights - HIT Consultant

Cleveland Clinic Awarded $7.2M NIH Grant for to Study MRI-Based Biomarker in Multiple Sclerosis

by Fred Pennic 06/12/2020 Leave a Comment

Cleveland Clinic Awarded $7.2M NIH Grant for to Study MRI-Based Biomarker in Multiple Sclerosis

What You Should Know: - Cleveland Clinic-led research team has been awarded a $7.2M grant from the National Institutes of Health (NIH) to support a multi-center study to study CVS, an MRI-based biomarker identified in multiple sclerosis associated white matter lesion. - The prospective study, referred to as CAVS-MS, will enroll 400 patients with typical or atypical presentations of MS at 11 participating centers in North America, with Cleveland Clinic serving as
Read More

Non-Invasive Technology for Measuring & Monitoring Liver Fat

by Scott Howell, D.O., MPH&TM, CPE, Advisor to Echosens 05/27/2020 Leave a Comment

As part of the growing awareness about chronic disease, it’s important to understand the relationship between nonalcoholic fatty liver disease (NAFLD), an asymptomatic condition characterized by elevated levels of fat in the liver, and diabetes. As a common complication of Type 2 diabetes and obesity, NAFLD can be overlooked comorbidity. Diabetes is one of the leading causes of disability and death in the United States. One in 10 Americans have diabetes – more than 30 million people – and
Read More

Machine Learning Will Transform Medicine, but Only if We Use it Right

by Natalie LaFranzo, PhD is VP, Market Development of Cofactor Genomics 05/12/2020 Leave a Comment

Natalie LaFranzo

World chess champion Garry Kasparov made headlines all over the world in 1997 for something that he probably wasn’t very excited about. He lost a chess match. To a computer. It was an IBM supercomputer called Deep Blue and its victory in that New York City match marked the first time a reigning world chess champion had been defeated by a computer under tournament conditions. It was also a symbolically significant event, the first sign that artificial intelligence could become equal to or even
Read More

AiCure Launches Platform to Remotely Capture Digital Biomarkers in Clinical Trials

by Fred Pennic 04/28/2020 Leave a Comment

AiCure Launches Platform to Remotely Capture Digital Biomarkers in Clinical Trials

What You Should Know: - AiCure launches digital biomarker platform to remotely detect subtle changes in a patient's condition, leverages computer vision and AI to gather and analyze visual and auditory cues directly through the patient's smartphone camera. - AiCure appoints Ed Ikeguchi, M.D. as its Chief Executive Officer (CEO) to advance AiCure's commitment to improving holistic health through an understanding of the science behind human responses to illness and treatment. AiCure,
Read More

Biofourmis Acquires Digital Therapeutics Oncology Startup Gaido Health

by Fred Pennic 04/16/2020 Leave a Comment

Biofourmis Expands into Oncology Market with Strategic Acquisition of Gaido Health

What You Should Know: - Boston-based digital therapeutics startup Biofourmis acquires LA-based Gaido Health from Takeda Pharmaceuticals, in a strategic deal that expands Biofourmis’ portfolio in the oncology space. - Gaido Health—a digital therapeutics company focused on the oncology market—was part of Takeda Digital Ventures, Takeda’s corporate technology investment and incubation arm. - With Gaido Health’s and Biofourmis’ dual focus on remote monitoring with wearables
Read More

One Drop Acquires Sano’s Continuous Glucose Sensing Platform

by Fred Pennic 04/13/2020 Leave a Comment

One Drop Acquires Sano’s Continuous Glucose Sensing Platform

What You Should Know: - One Drop has acquired all the assets and intellectual property of Sano Intelligence, Inc. which include Sano's continuous glucose sensing platform. - One Drop will leverage the acquired assets, including silicon-sensing production infrastructure, to design, produce, and commercialize a painless, silicon-based continuous health sensing platform for use across multiple conditions. One Drop, a New York City-based provider of digital care solutions for people
Read More

Analysis: Applying AI in the Fight Against The Coronavirus

by Dr. Ulrik Kristensen, Senior Market Analyst at Signify Research 04/01/2020 Leave a Comment

The Many Faces of AI in Clinical Trials

Drug discovery is a notoriously long, complex and expensive process requiring the concerted efforts of the world’s brightest minds. The complexity in understanding human physiology and molecular mechanisms is increasing with every new research paper published and for every new compound tested. As the world is facing a new challenge in trying to both adapt to and defend itself against the coronavirus, artificial intelligence is offering new hope that a cure might be developed faster than ever
Read More

Stanford Alumni Scientists, Physicians Launch StartX Med COVID-19 Task Force

by Jasmine Pennic 03/19/2020 Leave a Comment

Stanford Alumni Scientists and Physicians Launch StartX Med COVID-19 Task Force

What You Should Know: - More than 1500 Stanford faculty and alumni announced the launch of StartX Med COVID-19 Task Force featuring 70+ StartX Med Innovators with medical breakthroughs for the prevention, diagnostics, and treatment of coronavirus mobilize efforts to fast-track public health needs during the pandemic. - The StartX Med COVID-19 Task Force will collaborate on outreach to government agencies, regulatory bodies and healthcare systems in the interest of public health for
Read More

Hong Kong’s Dept. of Health Taps Biofourmis’ Remote Monitoring Platform to Fight Coronavirus

by Fred Pennic 03/04/2020 Leave a Comment

Hong Kong’s Dept. of Health Taps Biofourmis’ Remote Monitoring Platform to Fight Coronavirus

What You Need to Know: - Boston-based Biofourmis’ AI-powered digital therapeutics technology has inked a deal with The University of Hong Kong and Hong Kong’s Department of Health to leverage its wearable, AI-powered remote monitoring platform to provide new insights to fight COVID-19 in a national disease monitoring program. - Biofourmis’ technology will remotely monitor coronavirus infected and suspected patients and apply personally predictive analytics to help patients and increase
Read More

The Many Faces of AI in Clinical Trials

by Dr. Ulrik Kristensen, Senior Market Analyst at Signify Research 02/28/2020 Leave a Comment

The Many Faces of AI in Clinical Trials

AI is being applied in several aspects for the clinical trial process today. From analyzing real-world data and scientific information to providing improved patient stratification and predictive outcomes, and assisting with different aspects of clinical trial operations. Here are some of the technologies using AI and machine learning in the clinical trial space today, outlining how they fit within the clinical trial ecosystem and discuss the impact on future clinical trial designs. The
Read More

  • Previous Page
  • Go to page 1
  • Interim pages omitted …
  • Go to page 6
  • Go to page 7
  • Go to page 8
  • Go to page 9
  • Go to page 10
  • Interim pages omitted …
  • Go to page 12
  • Next Page

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

Digital Health Funding Q3 2025: Choppy Undercurrents Beneath a Steady Surface

Featured Interview

ConcertAI VP Shares View on AI Hallucinations and the Fabricated Data Crisis in Scientific Publishing

Most-Read

Qualtrics Acquires Press Ganey Forsta for $6.75B to Create the Most Comprehensive AI Experience Platform

Qualtrics Acquires Press Ganey Forsta for $6.75B to Create the Most Comprehensive AI Experience Platform

Pfizer and Trump Administration Announce Landmark Agreement to Lower Drug Costs

Pfizer and Trump Administration Announce Landmark Agreement to Lower Drug Costs

KLAS Report: Epic's Native Ambient Speech Tool Reshapes Customer AI Strategies

KLAS Report: Epic’s Native Ambient Speech Tool Reshapes Customer AI Strategies

Epic Unveils MyChart Central and New APIs to Advance Interoperability at Open@Epic

Epic Outlines Roadmap for Next-Generation Data Sharing at Open@Epic

Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys

Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys

RevSpring to Acquire Kyruus Health, Creating a Unified Patient Experience

RevSpring to Acquire Kyruus Health, Creating a Unified Patient Experience

Oracle Confirms Layoffs in Kansas City

Oracle Confirms Layoffs in Kansas City

Philips Future Health Index 2025: AI and Digital Tech Can Help Solve Cardiac Care Crisis

Philips Future Health Index 2025: AI and Digital Tech Can Help Solve Cardiac Care Crisis

Optain Health Secures $26M to Advance AI-Powered Retinal Screening

Optain Health Secures $26M for AI-Powered Retinal Screening

Sutter Health and Epic Launch "Sutter Sync" to Optimize Remote Chronic Care

Sutter Health and Epic Launch “Sutter Sync” to Optimize Remote Chronic Care

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |